Research analysts at Cantor Fitzgerald decreased their FY2025 earnings per share estimates for Beam Therapeutics in a note issued to investors on Wednesday, February 26th. Cantor Fitzgerald analyst R.

Xometry (NASDAQ:XMTR – Free Report) had its target price upped by Cantor Fitzgerald from $12.00 to $20.00 in a research note issued to investors on Wednesday morning,Benzinga reports. The brokerage ...

Lone Star Funds swooped in to purchase the $343 million loan portfolio, Bloomberg reported. The company acquired the loan ...

We recently compiled a list of the 10 Best Stocks Under $50 to Buy Right Now. In this article, we are going to take a look at ...

As an enterprise engaged in the development, manufacturing and commercialization of specialty plasma-derived therapeutics, Kamada Ltd (NASDAQ: KMDA), plays an important role in helping address rare ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on 89bio (ETNB – Research Report) and Lemaitre ...

Rocket Lab USA Inc.'s stock initially tumbled in the wake of the company's fourth-quarter results Thursday, weighed down by weak outlook, although an analyst KeyBanc Capital Markets believes the ...

Latest news on Ireland's companies and busines organisations and their impact locally, nationally and globally.

Andrew Callos; Executive Vice President, Chief Commercial Officer; Cytokinetics Inc Fady Malik; Executive Vice President - Research and Development; Cytokinetics Inc Isaac Ciechanover; Executive Vice ...

Welcome to the Terawulf 2024 fourth quarter year-end earnings call. (Operator Instructions) It's now my pleasure to introduce John Larkin, senior Vice President, Director of Investor Relations. Thank ...

Gary Gillheeney; President, Chief Executive Officer, Director; Organogenesis Holdings Inc. David Francisco; Chief Financial Officer; Organogenesis Holdings Inc. Broo ...

James Arestia; Vice President, Investor Relations; Avepoint Inc. Tianyi Jiang; Chief Executive Officer, Director; AvePoint Inc. James Caci; Chief Financial Officer; ...